Journal of Clinical and Cellular Immunology
Open Access

The Significance and Mechanisms of Vaccine Immunology in Immune System and its Innovations in Vaccine Development Process

Author info »

Description

Vaccines play a crucial role in safeguarding public health by preventing the spread of infectious diseases. The field of vaccine immunology explores the intricate mechanisms by which vaccines stimulate the immune system to provide protection against harmful pathogens. This article aims to provide a comprehensive overview of vaccine immunology, covering key concepts such as the immune response, types of vaccines and the development process.

The immune system

The immune system is a complex network of cells, tissues and organs that work together to defend the body against harmful invaders, including bacteria, viruses and other pathogens. The immune system comprises two primary components: the innate immune system and the adaptive immune system.

The innate immune system acts as the body's first line of defense, providing rapid, non-specific responses to pathogens. Components such as skin, mucous membranes and certain white blood cells contribute to this initial defense. However, for long-term protection and a more targeted response, the adaptive immune system comes into play.

The adaptive immune system, characterized by the presence of immune cells like T cells and B cells, provides a highly specific response to pathogens. This specificity is crucial for recognizing and remembering specific antigens, which are foreign substances that trigger an immune response [1].

Vaccines and the immune response

Vaccines are designed to mimic natural infections, training the immune system to recognize and remember specific pathogens without causing the disease itself. The key to their success lies in their ability to trigger a robust immune response [2].

When a person is vaccinated, the vaccine introduces antigens from weakened or inactivated forms of the targeted pathogen. These antigens stimulate the immune system without causing the disease, prompting the production of antibodies and the activation of immune cells.

Antibodies are proteins produced by B cells that recognize and neutralize specific antigens. The primary function of antibodies is to bind to pathogens and mark them for destruction by other immune cells. Meanwhile, T cells play a crucial role in coordinating and regulating the immune response, ensuring an effective and targeted defense against the pathogen.

Memory cells, a subset of B and T cells, are pivotal in vaccineinduced immunity. These cells "remember" the specific antigens encountered during vaccination, providing a rapid and heightened response upon subsequent exposure to the actual pathogen. This immunological memory is the foundation of long-term protection conferred by vaccines [3].

Types of vaccines

Vaccines come in various types, each employing different strategies to stimulate the immune system. The main categories of vaccines include:

Inactivated or live attenuated vaccines: Inactivated vaccines contain killed versions of the pathogen, ensuring they cannot cause disease. Examples include the polio vaccine. Live attenuated vaccines use weakened forms of the pathogen that retain the ability to stimulate an immune response without causing illness. The Measles, Mumps and Rubella (MMR) vaccine is an example [4].

Subunit, recombinant and conjugate vaccines: Subunit vaccines contain only specific pieces of the pathogen, such as proteins or sugars. The hepatitis B vaccine is a subunit vaccine. Recombinant vaccines are produced by genetic engineering, incorporating harmless parts of the pathogen into a different microorganism. The Human Papilloma Virus (HPV) vaccine is an example. Conjugate vaccines combine a weak antigen with a strong one to enhance the immune response. This approach is used in vaccines against bacterial pathogens like Haemophilus influenzae type b (Hib).

Messenger Ribonucleic Acid (mRNA) vaccines: mRNA vaccines, a relatively recent innovation, provide genetic instructions to cells to produce a harmless piece of the pathogen. The immune system recognizes this piece as foreign, triggering a robust response. The Pfizer-BioNTech and Moderna COVID-19 vaccines are prominent examples [5].

Vaccine development process

Developing a vaccine is a complex and meticulous process that involves several stages, from initial research to widespread distribution. The key stages in vaccine development include:

Exploration and research: Scientists identify potential vaccine candidates by studying the biology of the pathogen and its interaction with the immune system.

Preclinical testing: In this stage, the vaccine is tested in the laboratory and on animals to assess its safety, efficacy and the optimal dosage.

Clinical trials: Clinical trials involve three phases, starting with a small group of volunteers in Phase I to assess safety and dosage. Phase II expands to a larger group, evaluating the vaccine's effectiveness. Phase III includes a large-scale trial to confirm efficacy and monitor side effects.

Regulatory approval: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), review the data from clinical trials before granting approval for public use.

Production and distribution: Once approved, vaccines undergo large-scale production, followed by distribution to healthcare providers and vaccination centers [6].

Importance of herd immunity

Vaccine immunology extends beyond individual protection to the concept of herd immunity. Herd immunity occurs when a significant portion of the population is immune to a particular disease, either through vaccination or previous infection. This reduces the spread of the pathogen, protecting vulnerable individuals who cannot be vaccinated, such as those with certain medical conditions or allergies [7].

Herd immunity is particularly crucial in preventing outbreaks of highly contagious diseases and plays a vital role in achieving global health goals. The recent global efforts to vaccinate against COVID-19 underscore the importance of herd immunity in controlling the spread of infectious diseases on a large scale [8].

Challenges and future directions

While vaccines have been instrumental in controlling and preventing numerous infectious diseases, challenges persist. Some pathogens are challenging to target with traditional vaccine approaches, necessitating ongoing research into innovative strategies [9].

The future of vaccine immunology holds promise with advancements in technology and continued research into emerging infectious diseases, novel vaccine platforms and strategies to enhance vaccine accessibility will contribute to global efforts to combat infectious threats [10].

Conclusion

Vaccine immunology is a dynamic field that continues to evolve with scientific advancements. Understanding the immune response, the different types of vaccines and the intricacies of vaccine development is crucial for promoting public health and preventing the spread of infectious diseases. Although vaccines effectively control infectious diseases, there is still hesitancy and misinformation. Advancements in technology, like mRNA vaccines, offer potential for rapid responses. Global efforts to combat infectious threats will benefit from continued research and innovative strategies. As researchers and healthcare professionals work collaboratively, the ongoing progress in vaccine immunology will undoubtedly contribute to a healthier and more resilient global community.

References

1. Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, et al. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals. 2020;66:35-40.

   [Crossref] [Google Scholar] [PubMed]

2. Murphy KR, Patel NC, Ein D, Hudelson M, Kodoth S, Marshall GD, et al. Insights from American College of Allergy, Asthma and Immunology COVID-19 vaccine task force: allergic reactions to mRNA SARS-CoV-2 vaccines. Ann Allergy Asthma Immunol. 2021;126(4):319-320.

   [Crossref] [Google Scholar] [PubMed]

3. D'Souza MP, Rele S, Haynes BF, Hu DJ, Kaplan DL, Mamaghani S, et al. Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology. Vaccine. 2020;38(2):187-193.

   [Crossref] [Google Scholar] [PubMed]

4. Sullivan NL, Eberhardt CS, Wieland A, Vora KA, Pulendran B, Ahmed R. Understanding the immunology of the Zostavax shingles vaccine. Curr Opin Immunol. 2019;59:25-30.

   [Crossref] [Google Scholar] [PubMed]

5. Khatun F, Toth I, Stephenson RJ. Immunology of carbohydrate-based vaccines. Adv Drug Deliv Rev. 2020;165:117-126.

   [Crossref] [Google Scholar] [PubMed]

6. Russell HG, Tankersley MS. Recombinant zoster vaccine administration in an allergy and immunology practice: A medical and economic case. Ann Allergy Asthma Immunol. 2020;124(5):517-518.

   [Crossref] [Google Scholar] [PubMed]

7. Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, et al. The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells. J Immunol Methods. 2014;409:21-30.

   [Crossref] [Google Scholar] [PubMed]

8. Nami S, Mohammadi R, Vakili M, Khezripour K, Mirzaei H, Morovati H. Fungal vaccines, mechanism of actions and immunology: a comprehensive review. Biomed Pharmacother. 2019;109:333-344.

   [Crossref] [Google Scholar] [PubMed]

9. D'Argenio DA, Wilson CB. A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design. Immunity. 2010;33(4):437-440.

   [Crossref] [Google Scholar] [PubMed]

10. Topham DJ, Nguyen P, Sangster MY. Pandemic influenza vaccines: what they have taught us about B cell immunology. Curr Opin Immunol. 2018;53:203-208.

    [Crossref] [Google Scholar] [PubMed]